Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

CAMP4 THERAPEUTICS CORPORATION

CAMP
Current price
1.98 USD +0.37 USD (+22.98%)
Last closed 2.60 USD
ISIN US13463J1016
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 102 821 608 USD
Yield for 12 month -31.96 %
1Y
3Y
5Y
10Y
15Y
CAMP
21.11.2021 - 28.11.2021

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is currently in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: One Kendall Square, Cambridge, MA, United States, 02139

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

19.91 USD

P/E ratio

Dividend Yield

Current Year

+652 000 USD

Last Year

+186 230 000 USD

Current Quarter

+652 000 USD

Last Quarter

Current Year

Last Year

+66 979 000 USD

Current Quarter

Last Quarter

Key Figures CAMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -50 817 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM
PEG Ratio
Return On Equity TTM
Wall Street Target Price 19.91 USD
Revenue TTM
Book Value -158.04 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -37 927 000 USD
Earnings per share -2.64 USD
Diluted Eps TTM -2.64 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CAMP

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History CAMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation CAMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 315.31
Price Sales TTM
Enterprise Value EBITDA
Price Book MRQ

Financials CAMP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CAMP

For 52 weeks

1.91 USD 12.30 USD
50 Day MA 5.59 USD
Shares Short Prior Month 323 881
200 Day MA 7.03 USD
Short Ratio 3.48
Shares Short 348 758
Short Percent 1.81 %